These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 37451322

  • 1. Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.
    Lee YC, Chiou JT, Wang LJ, Chen YJ, Chang LS.
    Toxicol Appl Pharmacol; 2023 Sep 01; 474():116625. PubMed ID: 37451322
    [Abstract] [Full Text] [Related]

  • 2. Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells.
    Wang LJ, Lee YC, Chiou JT, Chen YJ, Chang LS.
    Cell Biol Toxicol; 2023 Oct 01; 39(5):2207-2225. PubMed ID: 35302183
    [Abstract] [Full Text] [Related]

  • 3. Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells.
    Wang LJ, Chiou JT, Lee YC, Chang LS.
    Biochem Pharmacol; 2022 Jan 01; 195():114865. PubMed ID: 34863979
    [Abstract] [Full Text] [Related]

  • 4. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
    Changchien JJ, Chen YJ, Huang CH, Cheng TL, Lin SR, Chang LS.
    Toxicol Appl Pharmacol; 2015 Apr 01; 284(1):33-41. PubMed ID: 25684043
    [Abstract] [Full Text] [Related]

  • 5. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
    Chiou JT, Huang CH, Wu TH, Wang LJ, Lee YC, Huang PW, Chang LS.
    Toxicol Appl Pharmacol; 2022 Jan 15; 435():115847. PubMed ID: 34963561
    [Abstract] [Full Text] [Related]

  • 6. AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells.
    Lee YC, Chiou JT, Chang LS.
    Biochem Pharmacol; 2023 Mar 15; 209():115442. PubMed ID: 36720359
    [Abstract] [Full Text] [Related]

  • 7. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
    Chiou JT, Huang NC, Huang CH, Wang LJ, Lee YC, Shi YJ, Chang LS.
    J Cell Physiol; 2021 Nov 15; 236(11):7356-7375. PubMed ID: 33982799
    [Abstract] [Full Text] [Related]

  • 8. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
    Chiou JT, Lee YC, Huang CH, Shi YJ, Wang LJ, Chang LS.
    Toxicol Appl Pharmacol; 2020 Jan 15; 387():114857. PubMed ID: 31837377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC, Chen YJ, Huang CH, Chang LS.
    Apoptosis; 2017 Mar 15; 22(3):406-420. PubMed ID: 27757735
    [Abstract] [Full Text] [Related]

  • 11. Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells.
    Sumi K, Tago K, Nakazawa Y, Takahashi K, Ohe T, Mashino T, Funakoshi-Tago M.
    Int J Mol Sci; 2022 Jan 11; 23(2):. PubMed ID: 35054935
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
    Lee YL, Chen CW, Liu FH, Huang YW, Huang HM.
    PLoS One; 2013 Jan 11; 8(4):e61939. PubMed ID: 23613979
    [Abstract] [Full Text] [Related]

  • 17. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
    Cheng Y, Hao Y, Zhang A, Hu C, Jiang X, Wu Q, Xu X.
    Int J Mol Med; 2018 Jan 11; 41(1):455-463. PubMed ID: 29115375
    [Abstract] [Full Text] [Related]

  • 18. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
    Perkins C, Kim CN, Fang G, Bhalla KN.
    Blood; 2000 Feb 01; 95(3):1014-22. PubMed ID: 10648417
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    Lin TY, Chen KC, Liu HJ, Liu AJ, Wang KL, Shih CM.
    PLoS One; 2016 Feb 01; 11(5):e0156260. PubMed ID: 27228340
    [Abstract] [Full Text] [Related]

  • 20. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
    Chiou JT, Lee YC, Wang LJ, Chang LS.
    Chem Biol Interact; 2022 Jul 01; 361():109978. PubMed ID: 35561756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.